The influence of swainsonine bring in the expression of N-glycan of osteosarcoma tumor stem cells
10.3969/j.issn.1006-5725.2017.01.11
- VernacularTitle:苦马豆素对骨肉瘤类肿瘤干细胞N-糖链表达的影响
- Author:
Sisheng ZHANG
;
Hongwei ZHAO
;
Haidan CHEN
- Keywords:
Swainsonine;
Osteosarcoma;
Cancer stem-like cells;
N-glycan
- From:
The Journal of Practical Medicine
2017;33(1):41-43
- CountryChina
- Language:Chinese
-
Abstract:
Objective Detecting the influence of swainsonine bring in the expression of N?glycan of osteosarcoma tumor stem cells. Methods LM8 cells were cultured in the culture medium (free of serum), then selected the LM8 cells of both CD44 and CD133 positive by magnetic activated cell sorting technique. Detecting the levels ofβ1, 6 branch N?glycan expression in the selected LM8 cells (treating by different doses of N?glycosylation inhibitor swainsonine) surface through the lectin binding assay (L?PHA). Results (96.5 ± 1.2)%of LM8 cells were both CD133 and CD44 positive which selected from all the LM8 cells in culture medium (free of serum) by magnetic activated cell sorting technique. Lectin binding assays shown that the bound rare of osteosarcoma tumor stem cells and L?PHA was (90.3 ± 2.1)%, which was higher than normal LM8 cells and L?PHA by (54.3 ± 3.1)%(P<0.05). The positive rare ofβ1, 6 branch N?glycan on the selected LM8 cells(treat with 1mg/mL swainsonine) surface was 90%. The positive rare of β1, 6 branch N?glycan on the selected LM8 cells (treat with 5mg/mL swainsonine) surface was 21%. Conclusion N?glycosylation inhibitor swainsonine plays a role in inhibiting the expression of N?glycan on cell surface of osteosarcoma tumor stem cell.
